Table 1. Baseline parameters of patients.
| Variable | RZB group (n=25) | DEX group (n=25) | Pa |
| CMT (µm) | |||
| Fovea | 460.3±125.2 | 479.1±100.6 | 0.561 |
| Parafovea | 412.8±73.1 | 447.7±76.0 | 0.104 |
| SCPD (µm) | |||
| Whole | 39.8±4.4 | 40.1±4.2 | 0.806 |
| Fovea | 26.8±5.8 | 29.3±5.2 | 0.115 |
| Parafovea | 41.5±4.9 | 41.3±4.3 | 0.878 |
| Parasuperior | 41.3±5.1 | 40.0±5.8 | 0.404 |
| Parainferior | 40.8±5.0 | 41.0±6.1 | 0.899 |
| DCPD (µm) | |||
| Whole | 45.9±5.1 | 45.4±5.1 | 0.730 |
| Fovea | 20.7±7.7 | 19.8±7.4 | 0.675 |
| Parafovea | 47.7±4.9 | 48.3±3.9 | 0.634 |
| Parasuperior | 48.8±4.9 | 46.5±6.0 | 0.144 |
| Parainferior | 47.7±3.9 | 47.5±5.0 | 0.875 |
| CCD (µm) | |||
| Whole | 61.3±7.0 | 63.0±1.8 | 0.254 |
| Fovea | 61.4±6.2 | 60.8±5.7 | 0.723 |
| Parafovea | 61.5±6.0 | 63.0±3.3 | 0.279 |
| Parasuperior | 59.9±8.8 | 62.0±2.1 | 0.252 |
| Parainferior | 61.5±6.3 | 62.0±3.3 | 0.727 |
| 4° MP (dB) | 5.7±5.5 | 5.8±5.3 | 0.948 |
| BCVA (logMAR) | 0.4±0.3 | 0.5±0.1 | 0.120 |
aStudent's t-test DEX group vs RZB group; CMT: Central macular thickness; SCPD: Superior capillary plexus density; DCPD: Deep capillary plexus density; CCD: Choriocapillaris density; MP: Microperimetry; BCVA: Best corrected visual acuity. Data are expressed as mean and standard deviation.